Search





Search





Markets
/
Stocks
/
roiv
/

Roivant Sciences Ltd

ROIV

Add to Watchlist

33.910USD

-0.610-1.77%

Close 07-31 16:00（ET）Quotes delayed by 15 min

24.43BMarket Cap

LossP/E TTM

Roivant Sciences Ltd

33.910

-0.610-1.77%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

7.00

Change

The current institutional shareholding score of Roivant Sciences Ltd is 7.00, ranking 50 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 79.01%, representing a quarter-over-quarter increase of 3.66%. The largest institutional shareholder is Andreas Halvorsen, holding a total of 6.23M shares, representing 0.92% of shares outstanding, with 0.53% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Dexcel Pharma Technologies, Ltd.

102.85M

Fidelity Management & Research Company LLC

65.72M

+8.22%

Morgan Stanley Investment Management Inc. (US)

54.36M

+33.71%

BlackRock Institutional Trust Company, N.A.

37.13M

+3.83%

Ramaswamy (Vivek)

33.71M

-28.38%

QVT Financial LP

26.39M

-6.03%

UBS Financial Services, Inc.

18.16M

+745.83%

State Street Investment Management (US)

17.36M

-7.16%